"Meanwhile, our share of the global pharmaceutical R&D market is declining. UK-based academics are now barred from the Horizon EU research programme, preventing them from participating in pioneering European work on the causes of disease."

https://www.ft.com/content/70e1733d-ecd9-4c8e-bd6a-54b31377ede3